Chemical Name:ethyl (E)-3-(4-ethoxyphenyl)prop-2-enoate

CAS.NO:1504-69-4

Synonyms:ethyl para-ethoxycinnamate;4-Aethoxy-zimtsaeure-aethylester;ethyl p-ethoxycinnamate;ethyl 4-ethoxycinnamate

Molecular Formula:C₁₃H₁₆O₃

Molecular Weight:220.26400

HS Code:2918990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:339.7ºC at 760mmHg

Density:1.061g/cm3

Index of Refraction:1.534

PSA:35.53000

Exact Mass:220.11000

LogP:2.66160

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like ethyl para-ethoxycinnamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 4-ethoxycinnamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl p-ethoxycinnamate Use and application,ethyl p-ethoxycinnamate technical grade,usp/ep/jp grade.

Related News: China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. ethyl (E)-3-(4-ethoxyphenyl)prop-2-enoate manufacturer The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%. ethyl (E)-3-(4-ethoxyphenyl)prop-2-enoate supplier China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. ethyl (E)-3-(4-ethoxyphenyl)prop-2-enoate vendor CROS NT built up its own biometric services portfolio: clinical data management, biostatistics, statistical programming and medical writing, through a series of acquisitions in the early 2010s. In 2013, CROS NT established a foothold in the U.S. with its purchase of Stat-Tech Services, which had a presence in the medical devices sector. CROS NT followed up the next year with its buy of biometrics services provider MDSL International to broaden its U.K. branch. ethyl (E)-3-(4-ethoxyphenyl)prop-2-enoate factory The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.